Sakar Healthcare Limited has been honored with a prestigious recognition award from the Ethiopian Pharmaceutical Supply Services (EPSS) for its outstanding performance during the 2024-25 period. The company received a crystal trophy acknowledging its excellence in fulfilling contractual commitments as one of the best suppliers.

Award Recognition Details

The Ethiopian Pharmaceutical Supply Services formally recognized Sakar Healthcare's exceptional service delivery and commitment to contractual obligations. The award ceremony highlighted the company's consistent performance standards and reliability in the Ethiopian pharmaceutical supply chain.

Partnership Acknowledgment

The Director General at EPSS expressed appreciation for Sakar Healthcare's valued partnership and emphasized the importance of maintaining this momentum for future business opportunities. The recognition specifically highlighted the company's remarkable performance and excellence in meeting contractual commitments throughout the award period.

The EPSS leadership indicated positive expectations for continued collaboration, including new business ventures and refill orders to Ethiopia. This recognition strengthens Sakar Healthcare's position in the Ethiopian pharmaceutical market and demonstrates its capability to meet international supply standards.

Regulatory Disclosure

Sakar Healthcare disclosed this achievement under Regulation 30 of the LODR (Listing Obligations and Disclosure Requirements) regulations. The company communicated this development to the National Stock Exchange of India, ensuring transparency with stakeholders and investors about this significant business milestone.

The formal disclosure was signed by Bharat Soni, Company Secretary and Compliance Officer, emphasizing the company's commitment to regulatory compliance and stakeholder communication. This recognition represents a notable achievement in Sakar Healthcare's international business operations and supplier relationships.

Sakar Healthcare has delivered exceptional financial performance in its third quarter results, showcasing significant growth across key revenue and profitability metrics. The healthcare company demonstrated robust operational performance with substantial year-on-year improvements in revenue, net profit, and EBITDA, reflecting strong business momentum during the reporting period.

Comprehensive Financial Performance

The company's Q3 results highlight impressive growth across multiple financial parameters, with revenue showing strong expansion alongside substantial improvements in both bottom-line and operational profitability.

Strong Revenue and Profitability Growth

Sakar Healthcare achieved revenue of ₹703 million in the third quarter, representing a substantial increase from ₹434 million recorded in the corresponding quarter of the previous year. This translates to a robust year-on-year growth rate of 62%, demonstrating the company's strong market performance.

The company's profitability metrics showed even more impressive growth, with net profit reaching ₹102 million compared to ₹45 million in the previous year's third quarter, marking an exceptional 127% year-on-year increase. The company's EBITDA performance also showed solid growth, rising to ₹186 million from ₹118 million, representing a 58% year-on-year increase.

Operational Efficiency Analysis

While the company demonstrated strong absolute growth in revenue and profitability metrics, the EBITDA margin experienced a slight decline to 26.4% from 27.1% in the corresponding period last year. Despite this marginal compression, the substantial growth in absolute revenue, EBITDA, and net profit figures reflects the company's ability to scale operations effectively and maintain competitive positioning in the healthcare sector.

Market Impact

The robust financial results demonstrate Sakar Healthcare's strong execution capabilities and operational excellence across both revenue generation and profit optimization. The significant growth in revenue, net profit, and EBITDA showcases the company's effective business strategy implementation and its ability to capitalize on market opportunities in the healthcare industry, positioning it well for continued growth momentum.